PYRIMIDINONES AS FACTOR XIA INHIBITORS

The present invention provides a compound which is (9R,13S)-13-{4-[5-chloro-2-(4-chloro-1H-1,2,3-triazol-1-yl)phenyl]-6-oxo-1,6-dihydropyrimidin-1-yl}-3-(difluoromethyl)-9-methyl-3,4,7,15-tetraazatricyclo[12.3.1.02,6]octadeca-1(18),2(6),4,14,16-pentaen-8-one trifluoroacetate, or a stereoisomer or ta...

Full description

Saved in:
Bibliographic Details
Main Authors ZHU, Yeheng, ORWAT, Michael J, PABBISETTY, Kumar Balashanmuga, CORTE, James R, YANG, Wu, SMITH II, Leon M, DILGER, Andrew K, WANG, Yufeng, PINTO, Donald J.P, FANG, Tianan, DE LUCCA, Indawati, EWING, William R, WEXLER, Ruth R
Format Patent
LanguageEnglish
French
German
Published 09.11.2016
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The present invention provides a compound which is (9R,13S)-13-{4-[5-chloro-2-(4-chloro-1H-1,2,3-triazol-1-yl)phenyl]-6-oxo-1,6-dihydropyrimidin-1-yl}-3-(difluoromethyl)-9-methyl-3,4,7,15-tetraazatricyclo[12.3.1.02,6]octadeca-1(18),2(6),4,14,16-pentaen-8-one trifluoroacetate, or a stereoisomer or tautomer thereof. This invention also relates to pharmaceutical compositions comprising this compound and their use in the treatment of thromboembolic disorders.
AbstractList The present invention provides a compound which is (9R,13S)-13-{4-[5-chloro-2-(4-chloro-1H-1,2,3-triazol-1-yl)phenyl]-6-oxo-1,6-dihydropyrimidin-1-yl}-3-(difluoromethyl)-9-methyl-3,4,7,15-tetraazatricyclo[12.3.1.02,6]octadeca-1(18),2(6),4,14,16-pentaen-8-one trifluoroacetate, or a stereoisomer or tautomer thereof. This invention also relates to pharmaceutical compositions comprising this compound and their use in the treatment of thromboembolic disorders.
Author WEXLER, Ruth R
SMITH II, Leon M
PINTO, Donald J.P
DE LUCCA, Indawati
YANG, Wu
CORTE, James R
WANG, Yufeng
FANG, Tianan
PABBISETTY, Kumar Balashanmuga
ORWAT, Michael J
DILGER, Andrew K
EWING, William R
ZHU, Yeheng
Author_xml – fullname: ZHU, Yeheng
– fullname: ORWAT, Michael J
– fullname: PABBISETTY, Kumar Balashanmuga
– fullname: CORTE, James R
– fullname: YANG, Wu
– fullname: SMITH II, Leon M
– fullname: DILGER, Andrew K
– fullname: WANG, Yufeng
– fullname: PINTO, Donald J.P
– fullname: FANG, Tianan
– fullname: DE LUCCA, Indawati
– fullname: EWING, William R
– fullname: WEXLER, Ruth R
BookMark eNrjYmDJy89L5WRQC4gM8vT1dPH08_dzDVZwDFZwc3QO8Q9SiPB0VPD08_B08gTygnkYWNMSc4pTeaE0N4OCm2uIs4duakF-fGpxQWJyal5qSbxrgLGBhaWluaWjoTERSgBx_yUn
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate PYRIMIDINONE ALS FAKTOR-XIA-HEMMER
PYRIMIDINONES UTILISÉES EN TANT QU'INHIBITEURS DU FACTEUR XIA
ExternalDocumentID EP3089979A1
GroupedDBID EVB
ID FETCH-epo_espacenet_EP3089979A13
IEDL.DBID EVB
IngestDate Fri Jul 19 12:50:17 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
French
German
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_EP3089979A13
Notes Application Number: EP20150747721
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20161109&DB=EPODOC&CC=EP&NR=3089979A1
ParticipantIDs epo_espacenet_EP3089979A1
PublicationCentury 2000
PublicationDate 20161109
PublicationDateYYYYMMDD 2016-11-09
PublicationDate_xml – month: 11
  year: 2016
  text: 20161109
  day: 09
PublicationDecade 2010
PublicationYear 2016
RelatedCompanies BRISTOL-MYERS SQUIBB COMPANY
RelatedCompanies_xml – name: BRISTOL-MYERS SQUIBB COMPANY
Score 3.058809
Snippet The present invention provides a compound which is...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title PYRIMIDINONES AS FACTOR XIA INHIBITORS
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20161109&DB=EPODOC&locale=&CC=EP&NR=3089979A1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LT8MwDLamgYAbDBDjpRxQbxXpY30cKtSnWqS1VVtQOU20pNIuY2JF_H2cqBtc4JaH5CRWvtiOYwfgzm71rp3pimxob6aMm4LKDUoKWWHMoBqjaisuc-apET_pj_WsHsFyGwsj8oR-ieSIiKgW8d6L83r9c4kViLeVm_tmiU3vD1HlBNJgHaP6olBbCjwnzLMg8yXfx5KUFo7G3Vum7aKhtIdatMnBED57PChl_VuiRMewnyOxVX8CI7aawKG__XhtAgfzwd-NxQF6m1OQ8pcCD5ogSbM0LIlbksj1q6wgdeKSJI0TL8FaeQYkCis_lnHAxW5xizDfTU07hzHa_OwCiGXpSmdaesPTw3T2K_8Nw1RUVBcoU1tqTWH6J5nLf_qu4IhzSQTT2dcw7j8-2Q1K1b65Ffz4Buhudj8
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LT8MwDLamgRg3GCDGMwfUW0Vf6-NQoT7VwvpQW1A5TbRLpV3GxIr4-7hRN7jALQ_JSax8sR3HDsCdUStNPVVEXpUXGo-bQuArlBS8SKkqyFSQanaZE8Vq8Kw8ltNyAMttLAzLE_rFkiMiomrEe8vO6_XPJZbL3lZu7qslNr0_-IXpcr11jOqLKBica5temriJwzkOlrg4M-XOvaUZFhpKe6hhax0YvBe7C0pZ_5Yo_hHsp0hs1R7DgK7GMHK2H6-N4SDq_d1Y7KG3OQEufc3woHHDOIm9nFg58S2nSDJShhYJ4yC0Q6zlp0B8r3ACHgec7xY399Ld1OQzGKLNT8-B6LoiNpquVF16mMZ4637D0EQJ1QWBSrWgT2DyJ5mLf_puYRQU0Ww-C-OnSzjsOMYC64wrGLYfn_QaJWxb3TDefAOeqnky
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=PYRIMIDINONES+AS+FACTOR+XIA+INHIBITORS&rft.inventor=ZHU%2C+Yeheng&rft.inventor=ORWAT%2C+Michael+J&rft.inventor=PABBISETTY%2C+Kumar+Balashanmuga&rft.inventor=CORTE%2C+James+R&rft.inventor=YANG%2C+Wu&rft.inventor=SMITH+II%2C+Leon+M&rft.inventor=DILGER%2C+Andrew+K&rft.inventor=WANG%2C+Yufeng&rft.inventor=PINTO%2C+Donald+J.P&rft.inventor=FANG%2C+Tianan&rft.inventor=DE+LUCCA%2C+Indawati&rft.inventor=EWING%2C+William+R&rft.inventor=WEXLER%2C+Ruth+R&rft.date=2016-11-09&rft.externalDBID=A1&rft.externalDocID=EP3089979A1